Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
- 1045 Press Releases ยท
- RSS
Published on Fri 11 Apr 2025 6:05:19 UTC
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
Published on Fri 11 Apr 2025 6:03:24 UTC
Report Ignores Medicare Contractors' Attack on Patient Care and the Biden Administration's Inaction on Payment Reform
Published on Fri 11 Apr 2025 5:56:54 UTC
- Revenues +11.6%, Adjusted EBITDA +13.1%
Published on Fri 11 Apr 2025 5:56:47 UTC
SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin depressions, has successfully passed the review of theInternational Cosmetic Ingredient Nomenclature Committee ("INC") and been officially granted a standardized International Nomenclature Cosmetic Ingredient ("INCI")name under the designation "Exosome." This marks the first engineered exosome worldwide to receive an INCI designation, highlighting ImmVira's leadership in the field and a significant advancement in the development of next-generation cosmetic ingredients.
Published on Fri 11 Apr 2025 5:53:30 UTC
BARGERSVILLE, Ind., April 10, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, PaulDelbert Winchester, MD is acknowledged as a Top Pinnacle Neonatologist for his contributions in Neonatology.
Published on Fri 11 Apr 2025 5:45:03 UTC
TORONTO, April 10, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that it will host a shareholder conference call to provide an update on its recent strategic developments, commercial progress, regulatory initiatives, and the next phase of its business growth.
Published on Fri 11 Apr 2025 5:44:53 UTC
STUART, Fla., April 10, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce the appointment of a new independent director, Sanjay Shrestha, to the Company's Board of Directors (the "Board"). Mr. Shrestha will serve as a member of the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee of the Board.
Published on Fri 11 Apr 2025 5:44:34 UTC
- Annonce d'une initiative mondiale pour la sant personnalise et la mdecine prventive lors de l'vnement
Published on Fri 11 Apr 2025 5:44:23 UTC
BIRMINGHAM, Ala., April 10, 2025 /PRNewswire/ -- Alabama Ophthalmology Associates ("AOA") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted individuals. AOA has sent notification of this incident to potentially impacted individuals and has provided resources to assist them.
Published on Fri 11 Apr 2025 5:44:22 UTC
SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics BiotechInc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep's development continues.
Published on Fri 11 Apr 2025 5:44:19 UTC
JACKSONVILLE, Ark., April 10, 2025 /PRNewswire/ -- Jacksonville Medical Care ("JMC") and Cabot Medical Care ("CMC") are providing notice of a recent data security incident that may have involved personal and/or protected health information. JMC and CMC take the privacy and security of all information within their possession very seriously. JMC and CMC have sent notice of this incident to potentially affected individuals and provided resources to assist them.
Published on Mon 7 Apr 2025 6:21:17 UTC
PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. forthe treatment of adults with schizophrenia and as a monotherapy or adjunct therapy for the treatment of adults with schizoaffective disorder.
Published on Mon 7 Apr 2025 6:21:15 UTC
, 7 2025 . /PRNewswire/ -- George Clinical, (CRO), , EmeraldClinical Trials. , , CRO, , , , 20 .
Published on Mon 7 Apr 2025 6:21:12 UTC
Nowa nazwa odzwierciedla rozwj firmy oraz jej wizj wspierania przejrzystoci i pewnoci w globalnych badaniach klinicznych.
Published on Mon 7 Apr 2025 6:21:09 UTC
Le nouveau nom reflte la croissance de l'entreprise et sa volont d'apporter certitude et transparence aux essais cliniques mondiaux.
Published on Mon 7 Apr 2025 6:21:04 UTC
El nuevo nombre refleja el crecimiento de la empresa y su visin de ayudar a brindar certeza y transparencia a los ensayos clnicos globales.
Published on Mon 7 Apr 2025 6:21:01 UTC
Der neue Name spiegelt das Wachstum des Unternehmens und seine Vision wider, Sicherheit und Transparenz bei globalen klinischen Studien zu schaffen
Published on Mon 7 Apr 2025 6:20:59 UTC
Nov nzev odr rst spolenosti a vizi pomhat vnet jistotu a transparentnost do globlnch klinickch studi
Published on Mon 7 Apr 2025 6:20:56 UTC
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases
Published on Mon 7 Apr 2025 6:20:50 UTC
World Health Day Statement by Education Cannot Wait Director Yasmine Sherif
Published on Mon 7 Apr 2025 6:18:49 UTC
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases
Published on Mon 7 Apr 2025 6:18:13 UTC
SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic planning, meticulous design, efficient execution, and comprehensiveregulatory compliance of the company's global clinical development efforts, ensuring adherence to the most stringent international regulatory standards.
Published on Mon 7 Apr 2025 6:18:12 UTC
NUEVA YORK, 7 de abril de 2025 /PRNewswire/ -- Ypsomed y Sidekick Health lanzan una solucin de salud digital integrada para ofrecer un mejor apoyo a las personas con obesidad. Los autoinyectores de Ypsomed se integran a la perfeccin con la aplicacin de salud digital y apoyo para enfermedades crnicas de Sidekick para ayudar a los pacientes que usan terapias inyectables basadas en GLP-1 a gestionar su tratamiento de forma ms eficaz.
Published on Mon 7 Apr 2025 6:18:09 UTC
NEW YORK, April 7, 2025 /PRNewswire/ -- Ypsomedand Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively.
Published on Mon 7 Apr 2025 6:18:07 UTC
NEW YORK, April 7, 2025 /PRNewswire/ -- Ypsomed and Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities